- Home
- YCBD vs HSDT Comparison
YCBD vs HSDT Comparison
Compare YCBD & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YCBD
- HSDT
- Stock Information
- Founded
- YCBD 2015
- HSDT 2014
- Country
- YCBD United States
- HSDT United States
- Employees
- YCBD N/A
- HSDT N/A
- Industry
- YCBD Biotechnology: Pharmaceutical Preparations
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- YCBD Health Care
- HSDT Health Care
- Exchange
- YCBD Nasdaq
- HSDT Nasdaq
- Market Cap
- YCBD 1.9M
- HSDT 1.8M
- IPO Year
- YCBD N/A
- HSDT N/A
- Fundamental
- Price
- YCBD $0.46
- HSDT $0.47
- Analyst Decision
- YCBD
- HSDT Buy
- Analyst Count
- YCBD 0
- HSDT 2
- Target Price
- YCBD N/A
- HSDT $24.00
- AVG Volume (30 Days)
- YCBD 193.9K
- HSDT 116.7K
- Earning Date
- YCBD 12-20-2024
- HSDT 11-12-2024
- Dividend Yield
- YCBD N/A
- HSDT N/A
- EPS Growth
- YCBD N/A
- HSDT N/A
- EPS
- YCBD N/A
- HSDT N/A
- Revenue
- YCBD $20,636,546.00
- HSDT $502,000.00
- Revenue This Year
- YCBD N/A
- HSDT $16.41
- Revenue Next Year
- YCBD $9.38
- HSDT $31.97
- P/E Ratio
- YCBD N/A
- HSDT N/A
- Revenue Growth
- YCBD N/A
- HSDT N/A
- 52 Week Low
- YCBD $0.42
- HSDT $0.37
- 52 Week High
- YCBD $1.73
- HSDT $9.50
- Technical
- Relative Strength Index (RSI)
- YCBD 46.39
- HSDT 39.76
- Support Level
- YCBD $0.42
- HSDT $0.44
- Resistance Level
- YCBD $0.52
- HSDT $0.58
- Average True Range (ATR)
- YCBD 0.05
- HSDT 0.06
- MACD
- YCBD -0.00
- HSDT 0.00
- Stochastic Oscillator
- YCBD 29.63
- HSDT 4.17
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.